Search Press releases Keywords From To 4 Feb 2022 Disposals of own shares Read More 4 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Read More 2 Feb 2022 Transparency notification FMR LLC. Read More 2 Feb 2022 UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years Read More 1 Feb 2022 UCB Commences Tender Offer to Acquire Zogenix, Inc. Read More 28 Jan 2022 Disposals of own shares Read More Pagination First page Previous page Previous … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Page 39 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
